Gang Deng Selected Research

Prostatic Neoplasms (Prostate Cancer)

9/2023	YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH.
7/2022	Fibroblast-like Synoviocytes-derived Exosomal PCGEM1 Accelerates IL-1β-induced Apoptosis and Cartilage Matrix Degradation by miR-142-5p/RUNX2 in Chondrocytes.
1/2021	Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARγ/MMP-9 signals.
7/2020	Mechanism of Notch1‑saRNA‑1480 reversing androgen sensitivity in human metastatic castration‑resistant prostate cancer.
1/2020	FAM46C inhibits cell proliferation and cell cycle progression and promotes apoptosis through PTEN/AKT signaling pathway and is associated with chemosensitivity in prostate cancer.
9/2015	Emodin inhibits the proliferation of PC3 prostate cancer cells in vitro via the Notch signaling pathway.
3/2015	CSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.
2/2008	[Curcumin inhibits the expression of vascular endothelial growth factor and androgen-independent prostate cancer cell line PC-3 in vitro].
2/2006	[Association between the polymorphism of CYP17 gene and risk of prostate cancer in chinese vigurs men].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gang Deng Research Topics

Disease

52	Neoplasms (Cancer) 04/2024 - 09/2005
14	Glioma (Gliomas) 04/2024 - 01/2015
12	Neoplasm Metastasis (Metastasis) 11/2022 - 05/2005
9	Glioblastoma (Glioblastoma Multiforme) 12/2023 - 01/2011
9	Prostatic Neoplasms (Prostate Cancer) 09/2023 - 02/2006
9	Ischemic Stroke 04/2023 - 01/2015
9	Stroke (Strokes) 10/2022 - 06/2017
9	Compression Fractures (Compression Fracture) 02/2017 - 03/2008
7	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2017
6	Brain Neoplasms (Brain Tumor) 01/2022 - 03/2018
6	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 09/2015
5	Ischemia 12/2023 - 06/2012
5	Inflammation (Inflammations) 12/2023 - 01/2018
5	Pathologic Constriction (Stenosis) 10/2023 - 02/2007
5	Cholangiocarcinoma 01/2022 - 01/2011
5	Edema (Dropsy) 01/2019 - 09/2003
4	Urinary Bladder Neoplasms (Bladder Cancer) 05/2023 - 01/2017
4	Aortic Dissection 01/2023 - 11/2012
4	Squamous Cell Carcinoma of Head and Neck 11/2022 - 05/2005
4	Memory Disorders (Memory Loss) 10/2019 - 01/2015
4	Liver Neoplasms (Liver Cancer) 01/2019 - 08/2011
4	Carcinoma (Carcinomatosis) 03/2018 - 05/2005
3	Demyelinating Diseases (Demyelinating Disease) 01/2024 - 01/2021
3	Neuromyelitis Optica (Devic's Disease) 01/2024 - 01/2021
3	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2023 - 05/2016
3	Hypertension (High Blood Pressure) 04/2023 - 11/2012
3	Reperfusion Injury 03/2023 - 07/2022
3	Brain Ischemia (Cerebral Ischemia) 01/2023 - 06/2017
3	Thrombocytopenia (Thrombopenia) 01/2023 - 10/2014
3	COVID-19 01/2021 - 11/2020
3	Tremor (Tremors) 11/2020 - 04/2019
3	Breast Neoplasms (Breast Cancer) 01/2020 - 10/2019
3	Carcinogenesis 01/2020 - 11/2013
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 12/2016 - 01/2015
3	Osteoporosis 09/2012 - 10/2011
2	Wounds and Injuries (Trauma) 01/2024 - 05/2016
2	Aneurysm (Aneurysms) 12/2023 - 01/2022
2	Liver Cirrhosis (Hepatic Cirrhosis) 12/2023 - 01/2008
2	Hemorrhage 04/2023 - 09/2019
2	Polyps 11/2022 - 06/2008
2	Infections 10/2022 - 01/2022
2	Tuberculosis (Tuberculoses) 10/2022 - 05/2018
2	Cerebral Hemorrhage 09/2022 - 02/2018
2	Hypoxia (Hypoxemia) 07/2022 - 05/2016
2	Myocardial Infarction 01/2022 - 02/2017

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 09/2023 - 02/2008
12	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2011
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 02/2008
7	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2013
6	CholesterolIBA 10/2023 - 01/2008
5	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 12/2017
5	Circular RNAIBA 01/2022 - 06/2018
5	AndrogensIBA 01/2021 - 02/2008
4	Therapeutic UsesIBA 11/2022 - 01/2018
4	CateninsIBA 11/2022 - 12/2016
4	Peptides (Polypeptides)IBA 10/2022 - 08/2011
4	Indicators and Reagents (Reagents)IBA 01/2021 - 05/2005
4	AlkaloidsIBA 01/2021 - 01/2017
3	RNA (Ribonucleic Acid)IBA 12/2023 - 07/2020
3	Carbon Tetrachloride (Tetrachloromethane)IBA 12/2023 - 01/2008
3	BilirubinIBA 01/2023 - 01/2019
3	Hematoxylin (Haematoxylon)IBA 01/2023 - 02/2018
3	Eosine Yellowish-(YS) (Eosin)IBA 01/2023 - 02/2018
3	Betulinic AcidIBA 10/2022 - 01/2019
3	AutoantibodiesIBA 10/2022 - 01/2021
3	AntioxidantsIBA 10/2022 - 01/2018
3	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 02/2020
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 09/2015
3	AlbuminsIBA 01/2022 - 01/2013
3	Carbolines (Beta-Carbolines)IBA 01/2021 - 01/2017
3	HarmalineIBA 01/2021 - 01/2018
3	Harmine (Telepathine)IBA 01/2021 - 01/2018
3	Neurotransmitter Agents (Neurotransmitter)IBA 11/2020 - 01/2018
3	Scopolamine (Hyoscine)FDA Link 10/2019 - 01/2018
3	Glyburide (Glibenclamide)FDA LinkGeneric 01/2019 - 01/2018
3	Emodin (Archin)IBA 02/2018 - 09/2015
3	Polymethyl Methacrylate (Sol)IBA 02/2012 - 03/2008
3	Messenger RNA (mRNA)IBA 11/2008 - 02/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 01/2021
2	Long Noncoding RNAIBA 05/2023 - 07/2022
2	AldosteroneIBA 04/2023 - 10/2016
2	Caspase 3 (Caspase-3)IBA 01/2023 - 01/2013
2	Glucose (Dextrose)FDA LinkGeneric 09/2022 - 09/2015
2	PolyphenolsIBA 01/2022 - 02/2017
2	Histones (Histone)IBA 01/2022 - 01/2021
2	icariinIBA 01/2022 - 11/2019

Therapy/Procedure

18	Therapeutics 01/2024 - 01/2008
11	Vertebroplasty 02/2017 - 03/2008
10	Drug Therapy (Chemotherapy) 06/2022 - 09/2014
8	Stents 10/2023 - 02/2007
6	Immunotherapy 11/2022 - 09/2015
4	Endovascular Aneurysm Repair 01/2023 - 11/2012
4	Intravenous Administration 10/2022 - 01/2019
3	Lasers (Laser) 04/2016 - 01/2015
2	Craniotomy 12/2023 - 01/2023
2	Platelet Transfusion (Blood Platelet Transfusions) 01/2023 - 10/2014
2	Catheters 10/2022 - 08/2018
2	Hepatectomy 01/2022 - 10/2019
2	Aftercare (After-Treatment) 01/2022 - 08/2011